Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12125)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2014 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Herreros-Villanueva M, Bujanda L, Billadeau DD, Zhang JS. Embryonic stem cell factors and pancreatic cancer. World J Gastroenterol 2014; 20(9): 2247-2254 [PMID: 24605024 DOI: 10.3748/wjg.v20.i9.2247] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i9/2247.htm |
| Number | Citing Articles |
| 1 |
Mei-Yu Quan, Qiang Guo, Jiayu Liu, Ruo Yang, Jing Bai, Wei Wang, Yaxin Cai, Rui Han, Yu-Qing Lv, Li Ding, Daniel D. Billadeau, Zhenkun Lou, Saverio Bellusci, Xiaokun Li, Jin-San Zhang. An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00287
|
| 2 |
TAKAAKI MIYAKE, YOSHIO HONMA, TAKESHI URANO, NOBUO KATO, JUNJI SUZUMIYA. Combined treatment with tamoxifen and a fusicoccin derivative (ISIR-042) to overcome resistance to therapy and to enhance the antitumor activity of 5-fluorouracil and gemcitabine in pancreatic cancer cells. International Journal of Oncology 2015; 47(1): 315 doi: 10.3892/ijo.2015.2979
|
| 3 |
J. Löhr, Stephan Haas, Jens Kröger, Helmut Friess, Raimund Höft, Peter Goretzki, Christian Peschel, Markus Schweigert, Brian Salmons, Walter Gunzburg. Encapsulated Cells Expressing a Chemotherapeutic Activating Enzyme Allow the Targeting of Subtoxic Chemotherapy and Are Safe and Efficacious: Data from Two Clinical Trials in Pancreatic Cancer. Pharmaceutics 2014; 6(3): 447 doi: 10.3390/pharmaceutics6030447
|
| 4 |
Jan Strnadel, Sunkyu Choi, Ken Fujimura, Huawei Wang, Wei Zhang, Meghan Wyse, Tracy Wright, Emilie Gross, Carlos Peinado, Hyun Woo Park, Jack Bui, Jonathan Kelber, Michael Bouvet, Kun-Liang Guan, Richard L. Klemke. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. Cancer Research 2017; 77(8): 1997 doi: 10.1158/0008-5472.CAN-16-2594
|
| 5 |
Zhiqiang Fu, Guolin Li, Zhihua Li, Yingxue Wang, Yue Zhao, Shangyou Zheng, Huilin Ye, Yuming Luo, Xiaohui Zhao, Lusheng Wei, Yimin Liu, Qing Lin, Quanbo Zhou, Rufu Chen. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Cell Death Discovery 2017; 3(1) doi: 10.1038/cddiscovery.2017.4
|
| 6 |
Luka Culig, Xixia Chu, Vilhelm A. Bohr. Neurogenesis in aging and age-related neurodegenerative diseases. Ageing Research Reviews 2022; 78: 101636 doi: 10.1016/j.arr.2022.101636
|
| 7 |
Hengqiang Zhao, Shihong Wu, Hehe Li, Qingke Duan, Zhengle Zhang, Qiang Shen, Chunyou Wang, Tao Yin. ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer. Molecular Therapy - Oncolytics 2019; 14: 299 doi: 10.1016/j.omto.2019.07.005
|
| 8 |
Peng Pan, Ting Chen, Yanmin Zhang, Zhengyu Qi, Jie Qin, Guanghui Cui, Xin Guo. LIN28A inhibits lysosome‑associated membrane glycoprotein 1 protein expression in embryonic stem and bladder cancer cells. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8965
|
| 9 |
Jie-Zhuang Huang, Jian-Di Li, Gang Chen, Rong-Quan He. Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma. World Journal of Clinical Oncology 2024; 15(1): 62-88 doi: 10.5306/wjco.v15.i1.62
Abstract(371) |
Core Tip(358) |
Full Article(HTML)(1306)
|
Full Article with Cover (PDF)-21794K(63)
|
Full Article (Word)-7602K(18)
|
Audio-1081K(2)
|
Peer-Review Report-181K(43)
|
Answering Reviewers-211K(44)
|
Supplementary Material-64K(47)
|
Full Article (PDF)-21473K(87)
|
Full Article (XML)-137K(44)
|
Times Cited (0)
|
Total Visits (4114)
|
Open
|
| 10 |
Marta Herreros-Villanueva, Tze-Kiong Er, Luis Bujanda. Retinoic Acid Reduces Stem Cell–Like Features in Pancreatic Cancer Cells. Pancreas 2015; 44(6): 918 doi: 10.1097/MPA.0000000000000373
|
| 11 |
Homa Fatma, Hifzur R. Siddique. Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked?. Cancer and Metastasis Reviews 2024; 43(1): 423 doi: 10.1007/s10555-023-10144-9
|
| 12 |
Ai-Xi Sun, Chang-Jiang Liu, Zi-Qin Sun, Zhi Wei. NANOG: A promising target for digestive malignant tumors. World Journal of Gastroenterology 2014; 20(36): 13071-13078 doi: 10.3748/wjg.v20.i36.13071
|
| 13 |
K. Vanova, S. Boukalova, H. Gbelcova, L. Muchova, J. Neuzil, R. Gurlich, T. Ruml, L. Vitek. Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2343-9
|
| 14 |
Fan Yang, Pei Cui, Yu Lu, Xiaobo Zhang. Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells. Stem Cell Research & Therapy 2019; 10(1) doi: 10.1186/s13287-019-1360-4
|
| 15 |
Hamid Aria, Mahdieh Azizi, Shima Nazem, Behnam Mansoori, Farzaneh Darbeheshti, Anoosha Niazmand, Abdolreza Daraei, Yaser Mansoori. Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development. Heliyon 2024; 10(15): e35208 doi: 10.1016/j.heliyon.2024.e35208
|
| 16 |
Lionel Y.W. Leck, Yomna S. Abd El-Aziz, Kelly J. McKelvey, Kyung Chan Park, Sumit Sahni, Darius J.R. Lane, Jan Skoda, Patric J. Jansson. Cancer stem cells: Masters of all traits. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; : 167549 doi: 10.1016/j.bbadis.2024.167549
|
| 17 |
Bridget Mooney, Nurazhani Abdul-Raof, Yangzi Isabel Tian, Yubing Xie. Restriction of Cancer Metastatic Potential Using Embryonic Stem Cells Encapsulated in Alginate Hydrogel Microstrands. ACS Biomaterials Science & Engineering 2017; 3(8): 1769 doi: 10.1021/acsbiomaterials.7b00237
|
| 18 |
Diana Freitag, Aaron Lawson McLean, Michèle Simon, Arend Koch, Susanne Grube, Jan Walter, Rolf Kalff, Christian Ewald. NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades. Molecular Carcinogenesis 2017; 56(8): 1953 doi: 10.1002/mc.22653
|
| 19 |
Lisa-Marie Philipp, Umut-Ulas Yesilyurt, Arne Surrow, Axel Künstner, Anne-Sophie Mehdorn, Charlotte Hauser, Jan-Paul Gundlach, Olga Will, Patrick Hoffmann, Lea Stahmer, Sören Franzenburg, Hendrike Knaack, Udo Schumacher, Hauke Busch, Susanne Sebens. Epithelial and Mesenchymal-like Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Associated with Different Metastatic Propensities. Cancers 2024; 16(4): 686 doi: 10.3390/cancers16040686
|
| 20 |
Deepanshi Dhar, Gagan Deep, Sushil Kumar, Michael F. Wempe, Komal Raina, Chapla Agarwal, Rajesh Agarwal. Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. Molecular Carcinogenesis 2018; 57(9): 1166 doi: 10.1002/mc.22833
|
| 21 |
Srinivasa P Pothula, Zhihong Xu, David Goldstein, Andrew V Biankin, Romano C Pirola, Jeremy S Wilson, Minoti V Apte. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer. British Journal of Cancer 2016; 114(3): 269 doi: 10.1038/bjc.2015.478
|
| 22 |
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, Hamidreza Kabiri, Hosein Salehian-Dehkordi, Mohammad Abdolvand, Sharareh Salmanizadeh, Mohsen Rashidi, Anoosha Niazmand, Saba Ahmadi, Sara Feizbakhshan, Saber Kabiri, Nasimeh Vatandoost, Tayebeh Ranjbarnejad. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01873-0
|
| 23 |
Zhe Wang, Margot Zöller. Exosomes, metastases, and the miracle of cancer stem cell markers. Cancer and Metastasis Reviews 2019; 38(1-2): 259 doi: 10.1007/s10555-019-09793-6
|
| 24 |
L. G. Kondratyeva, T. V. Vinogradova, I. P. Chernov, E. D. Sverdlov. Master transcription regulators specifying cell-lineage fates in development as possible therapeutic targets in oncology. Russian Journal of Genetics 2015; 51(11): 1049 doi: 10.1134/S1022795415100099
|
| 25 |
Yosep Chong, Nishant Thakur, Kwang Yeol Paik, Eun Jung Lee, Chang Suk Kang. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6673-2
|
| 26 |
Sheeja Aravindan, Satish Kumar Ramraj, Somasundaram T. Somasundaram, Terence S. Herman, Natarajan Aravindan. Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer. Stem Cell Research & Therapy 2015; 6(1) doi: 10.1186/s13287-015-0173-3
|
| 27 |
Stephan Marquardt, Manish Solanki, Alf Spitschak, Julio Vera, Brigitte M. Pützer. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Seminars in Cancer Biology 2018; 53: 90 doi: 10.1016/j.semcancer.2018.06.006
|
| 28 |
Ming-Chen Yang, Hao-Chen Wang, Ya-Chin Hou, Hui-Ling Tung, Tai-Jan Chiu, Yan-Shen Shan. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0449-3
|
| 29 |
Shufeng Zhou, Mohamed Abdouh, Vincenzo Arena, Manuel Arena, Goffredo Orazio Arena, Joseph Najbauer. Reprogramming Malignant Cancer Cells toward a Benign Phenotype following Exposure to Human Embryonic Stem Cell Microenvironment. PLOS ONE 2017; 12(1): e0169899 doi: 10.1371/journal.pone.0169899
|
| 30 |
Yiming Zhang, Yiqiang Huang, Zhong Jin, Xiezhao Li, Bingkun Li, Peng Xu, Peng Huang, Chunxiao Liu. A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells. Tumor Biology 2016; 37(9): 11973 doi: 10.1007/s13277-016-5046-6
|
| 31 |
Hani M. Babiker, Irbaz B. Riaz, Syed R. Shah, Daniel D. Von Hoff, Mitesh J. Borad. Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma. Anti-Cancer Drugs 2017; 28(2): 127 doi: 10.1097/CAD.0000000000000437
|
| 32 |
Pojul Loying, Janvie Manhas, Sudip Sen, Biplab Bose, Chunhong Yan. Autoregulation and Heterogeneity in Expression of Human Cripto-1. PLOS ONE 2015; 10(2): e0116748 doi: 10.1371/journal.pone.0116748
|
| 33 |
Jian Li, Peisheng Sun, Zhongyi Yue, Dezhong Zhang, Kun You, Jianguo Wang. miR-144-3p Induces Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells by Targeting Proline-Rich Protein 11 Expression via the Mitogen-Activated Protein Kinase Signaling Pathway. DNA and Cell Biology 2017; 36(8): 619 doi: 10.1089/dna.2017.3656
|
| 34 |
Jingyang Zhou, Haihong Wang, Jinhui Che, Lu Xu, Weizhong Yang, Yunjiu Li, Wuyuan Zhou. Silencing of microRNA-135b inhibits invasion, migration, and stemness of CD24+CD44+ pancreatic cancer stem cells through JADE-1-dependent AKT/mTOR pathway. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01210-1
|
| 35 |
Brigitte M. Pützer, Manish Solanki, Ottmar Herchenröder. Advances in cancer stem cell targeting: How to strike the evil at its root. Advanced Drug Delivery Reviews 2017; 120: 89 doi: 10.1016/j.addr.2017.07.013
|
| 36 |
Philipp Mayer, Anne Kraft, Hagen R. Witzel, Nicole Marnet, Nina Hörner, Wilfried Roth, Stefan Heinrich, Thilo Hackert, Frank Bergmann, Hans-Ulrich Kauczor, Miriam Klauss, Matthias M. Gaida. Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging in Pancreatic Cancer is Associated with Tumor Hypoxia. Cancers 2020; 13(1): 89 doi: 10.3390/cancers13010089
|
| 37 |
Yiming Ma, Wei Yu, Anju Shrivastava, Rakesh K. Srivastava, Sharmila Shankar. Inhibition of pancreatic cancer stem cell characteristics by α‐Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog. Journal of Cellular and Molecular Medicine 2019; 23(4): 2719 doi: 10.1111/jcmm.14178
|
| 38 |
Claudia Di Carlo, Bebiana C. Sousa, Marcello Manfredi, Jessica Brandi, Elisa Dalla Pozza, Emilio Marengo, Marta Palmieri, Ilaria Dando, Michael J. O. Wakelam, Andrea F. Lopez-Clavijo, Daniela Cecconi. Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92752-5
|
| 39 |
Wei Yu, Yiming Ma, Sanjit K. Roy, Rashmi Srivastava, Sharmila Shankar, Rakesh K. Srivastava. Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1‐Cre and LSL‐KrasG12D) mice. Journal of Cellular and Molecular Medicine 2022; 26(2): 399 doi: 10.1111/jcmm.17092
|
| 40 |
Rohitesh Gupta, Frank Leon, Christopher M. Thompson, Ramakrishna Nimmakayala, Saswati Karmakar, Palanisamy Nallasamy, Seema Chugh, Dipakkumar R. Prajapati, Satyanarayana Rachagani, Sushil Kumar, Moorthy P. Ponnusamy. Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. British Journal of Cancer 2020; 122(11): 1661 doi: 10.1038/s41416-020-0772-3
|
| 41 |
Timothy L. Fitzgerald, James A. McCubrey. Pancreatic cancer stem cells: Association with cell surface markers, prognosis, resistance, metastasis and treatment. Advances in Biological Regulation 2014; 56: 45 doi: 10.1016/j.jbior.2014.05.001
|
| 42 |
Zhengle Zhang, Han Han, Yuping Rong, Kongfan Zhu, Zhongchao Zhu, Zhigang Tang, Chenglong Xiong, Jing Tao. Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0972-3
|
| 43 |
Fei Cui, Zhe‐xue Hao, Jin Li, Ya‐lei Zhang, Xu‐kai Li, Jian‐xing He. SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p. Molecular Genetics & Genomic Medicine 2020; 8(5) doi: 10.1002/mgg3.1195
|
| 44 |
Kalyani Patil, Farheen B. Khan, Sabah Akhtar, Aamir Ahmad, Shahab Uddin. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance. Cancer and Metastasis Reviews 2021; 40(3): 691 doi: 10.1007/s10555-021-09979-x
|
| 45 |
E. D. Sverdlov, V. V. Pleshkan, I. V. Alekseenko, T. V. Vinogradova, E. P. Kopantsev, D. A. Didych. Adult stem cells and other cancer residents. Part I. Molecular Genetics, Microbiology and Virology 2015; 30(3): 107 doi: 10.3103/S0891416815030064
|
| 46 |
Pan Wang, Wen-wu Wan, Shuang-Long Xiong, Hua Feng, Nan Wu. Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death Discovery 2017; 3(1) doi: 10.1038/cddiscovery.2016.105
|
| 47 |
Feng Jiao, Hai Hu, Ting Han, Cuncun Yuan, Lei Wang, Ziliang Jin, Zhen Guo, Liwei Wang. Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells. International Journal of Molecular Sciences 2015; 16(4): 6677 doi: 10.3390/ijms16046677
|
| 48 |
Adriana Harbuzariu, Gabriela Oprea-Ilies, Ruben Gonzalez-Perez. The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer. Medicines 2018; 5(3): 68 doi: 10.3390/medicines5030068
|
| 49 |
Xue-Fen He, Xiaoli Hu, Gao-Jing Wen, Zhiwei Wang, Wen-Jing Lin. O-GlcNAcylation in cancer development and immunotherapy. Cancer Letters 2023; 566: 216258 doi: 10.1016/j.canlet.2023.216258
|
| 50 |
Sei Sai, Toshifumi Wakai, Guillaume Vares, Shigeru Yamada, Takehiko Kamijo, Tadashi Kamada, Toshiyuki Shirai. Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cellsin vitroandin vivo. Oncotarget 2015; 6(8): 5517 doi: 10.18632/oncotarget.3584
|
| 51 |
Teodoro Luque-Martínez. Sensibilidad y elasticidad de las universidades españolas a los indicadores del Ranking de Shanghái (ARWU). Revista Española de Documentación Científica 2023; 46(1): e350 doi: 10.3989/redc.2023.1.1947
|
| 52 |
Mireia Mato Prado, Adam E Frampton, Justin Stebbing, Jonathan Krell. Gene of the month:NANOG. Journal of Clinical Pathology 2015; 68(10): 763 doi: 10.1136/jclinpath-2015-203238
|
| 53 |
Pablo Hernández-Camarero, Elena López-Ruiz, Carmen Griñán-Lisón, María Ángel García, Carlos Chocarro-Wrona, Juan Antonio Marchal, Julian Kenyon, Macarena Perán. Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47837-7
|
| 54 |
Deepa Bhartiya, Hiren Patel. Very small embryonic-like stem cells are involved in pancreatic regeneration and their dysfunction with age may lead to diabetes and cancer. Stem Cell Research & Therapy 2015; 6(1) doi: 10.1186/s13287-015-0084-3
|
| 55 |
Akram Tayanloo-Beik, Shayesteh Kokabi Hamidpour, Amirabbas Nikkhah, Rasta Arjmand, Ahmad Rezazadeh Mafi, Mostafa Rezaei-Tavirani, Bagher Larijani, Kambiz Gilany, Babak Arjmand. Cell Biology and Translational Medicine, Volume 22. Advances in Experimental Medicine and Biology 2023; 1470: 165 doi: 10.1007/5584_2023_791
|
| 56 |
Pierre V Candelaria, Antonio Rampoldi, Adriana Harbuzariu, Ruben R Gonzalez-Perez. Leptin signaling and cancer chemoresistance: Perspectives. World Journal of Clinical Oncology 2017; 8(2): 106-119 doi: 10.5306/wjco.v8.i2.106
|
| 57 |
Adriana Harbuzariu, Antonio Rampoldi, Danielle S Daley-Brown, Pierre Candelaria, Tia L Harmon, Crystal C Lipsey, Derrick J Beech, Alexander Quarshie, Gabriela Oprea Ilies, Ruben R Gonzalez-Perez. Leptin-Notch signaling axis is involved in pancreatic cancer progression. Oncotarget 2017; 8(5): 7740 doi: 10.18632/oncotarget.13946
|
| 58 |
Simple Mohanta, Gangotri Siddappa, Sindhu Govindan Valiyaveedan, Ravindra Dodda Thimmasandra Ramanjanappa, Debashish Das, Ramanan Pandian, Samanta Sekhar Khora, Moni Abraham Kuriakose, Amritha Suresh. Cancer stem cell markers in patterning differentiation and in prognosis of oral squamous cell carcinoma. Tumor Biology 2017; 39(6): 101042831770365 doi: 10.1177/1010428317703656
|
| 59 |
Sara Noorani, Shannon R. Nelson, Neil T. Conlon, Justine Meiller, Ekaterina Shcheglova, Alice Usai, Jojanneke Stoof, Letizia Palanga, Fiona O’Neill, Sandra Roche, Maura B. Cotter, Niall Swan, Naomi Walsh. Pancreatic Cancer 3D Cell Line Organoids (CLOs) Maintain the Phenotypic Characteristics of Organoids and Accurately Reflect the Cellular Architecture and Heterogeneity In Vivo. Organoids 2022; 1(2): 168 doi: 10.3390/organoids1020013
|
| 60 |
Ling Gao, Yijin Yang, Haiyan Xu, Ruqian Liu, Dechun Li, Han Hong, Mingde Qin, Yunliang Wang. miR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4. Tumor Biology 2014; 35(8): 8309 doi: 10.1007/s13277-014-2092-9
|
| 61 |
Mohammad Aslam Khan, Sanjeev Kumar Srivastava, Haseeb Zubair, Girijesh Kumar Patel, Sumit Arora, Moh'd Khushman, James Elliot Carter, Gregory Stephen Gorman, Seema Singh, Ajay Pratap Singh. Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer. Journal of Biological Chemistry 2020; 295(25): 8413 doi: 10.1074/jbc.RA119.011748
|
| 62 |
Xin-yu ZHOU, Liang-liang LIU, Wen-chao JIA, Chuan-ying PAN. Methylation profile of bovine Oct4 gene coding region in relation to three germ layers. Journal of Integrative Agriculture 2016; 15(3): 618 doi: 10.1016/S2095-3119(15)61100-5
|